142 related articles for article (PubMed ID: 37721513)
1. SAM: Self-adapting mixture prior to dynamically borrow information from historical data in clinical trials.
Yang P; Zhao Y; Nie L; Vallejo J; Yuan Y
Biometrics; 2023 Dec; 79(4):2857-2868. PubMed ID: 37721513
[TBL] [Abstract][Full Text] [Related]
2. Elastic priors to dynamically borrow information from historical data in clinical trials.
Jiang L; Nie L; Yuan Y
Biometrics; 2023 Mar; 79(1):49-60. PubMed ID: 34437714
[TBL] [Abstract][Full Text] [Related]
3. Robust meta-analytic-predictive priors in clinical trials with historical control information.
Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
[TBL] [Abstract][Full Text] [Related]
4. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
Hupf B; Bunn V; Lin J; Dong C
Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
[TBL] [Abstract][Full Text] [Related]
5. A scaled kernel density estimation prior for dynamic borrowing of historical information with application to clinical trial design.
Warren JL; Wang Q; Ciarleglio MM
Stat Med; 2024 Apr; 43(8):1615-1626. PubMed ID: 38345148
[TBL] [Abstract][Full Text] [Related]
6. Quantification of prior impact in terms of effective current sample size.
Wiesenfarth M; Calderazzo S
Biometrics; 2020 Mar; 76(1):326-336. PubMed ID: 31364156
[TBL] [Abstract][Full Text] [Related]
7. Historical controls in clinical trials: a note on linking Pocock's model with the robust mixture priors.
Callegaro A; Galwey N; Abellan JJ
Biostatistics; 2023 Apr; 24(2):443-448. PubMed ID: 37057610
[TBL] [Abstract][Full Text] [Related]
8. Unit information prior for adaptive information borrowing from multiple historical datasets.
Jin H; Yin G
Stat Med; 2021 Nov; 40(25):5657-5672. PubMed ID: 34302378
[TBL] [Abstract][Full Text] [Related]
9. Effects of globally obtained informative priors on bayesian safety performance functions developed for Australian crash data.
Afghari AP; Haque MM; Washington S; Smyth T
Accid Anal Prev; 2019 Aug; 129():55-65. PubMed ID: 31108237
[TBL] [Abstract][Full Text] [Related]
10. On efficient posterior inference in normalized power prior Bayesian analysis.
Han Z; Zhang Q; Wang M; Ye K; Chen MH
Biom J; 2023 Jun; 65(5):e2200194. PubMed ID: 36960489
[TBL] [Abstract][Full Text] [Related]
11. An adaptive power prior for sequential clinical trials - Application to bridging studies.
Ollier A; Morita S; Ursino M; Zohar S
Stat Methods Med Res; 2020 Aug; 29(8):2282-2294. PubMed ID: 31729275
[TBL] [Abstract][Full Text] [Related]
12. Assessing efficacy in important subgroups in confirmatory trials: An example using Bayesian dynamic borrowing.
Best N; Price RG; Pouliquen IJ; Keene ON
Pharm Stat; 2021 May; 20(3):551-562. PubMed ID: 33475231
[TBL] [Abstract][Full Text] [Related]
13. Bayesian Dynamic Borrowing of Historical Information with Applications to the Analysis of Large-Scale Assessments.
Kaplan D; Chen J; Yavuz S; Lyu W
Psychometrika; 2023 Mar; 88(1):1-30. PubMed ID: 35687222
[TBL] [Abstract][Full Text] [Related]
14. Addressing potential prior-data conflict when using informative priors in proof-of-concept studies.
Mutsvari T; Tytgat D; Walley R
Pharm Stat; 2016; 15(1):28-36. PubMed ID: 26762570
[TBL] [Abstract][Full Text] [Related]
15. A novel power prior approach for borrowing historical control data in clinical trials.
Shi Y; Li W; Liu GF
Stat Methods Med Res; 2023 Mar; 32(3):493-508. PubMed ID: 36601652
[TBL] [Abstract][Full Text] [Related]
16. Robust incorporation of historical information with known type I error rate inflation.
Calderazzo S; Wiesenfarth M; Kopp-Schneider A
Biom J; 2024 Jan; 66(1):e2200322. PubMed ID: 38063813
[TBL] [Abstract][Full Text] [Related]
17. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
Harun N; Liu C; Kim MO
Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Historical Data-Based Informative Prior on Benchmark Dose Estimation of Toxicogenomics.
Ji C; Shao K
Chem Res Toxicol; 2023 Aug; 36(8):1345-1354. PubMed ID: 37494567
[TBL] [Abstract][Full Text] [Related]
19. The power prior: theory and applications.
Ibrahim JG; Chen MH; Gwon Y; Chen F
Stat Med; 2015 Dec; 34(28):3724-49. PubMed ID: 26346180
[TBL] [Abstract][Full Text] [Related]
20. Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.
Brard C; Hampson LV; Gaspar N; Le Deley MC; Le Teuff G
BMC Med Res Methodol; 2019 Apr; 19(1):85. PubMed ID: 31018832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
